The FDA has issued an emergency use authorization for Regeneron's antibody cocktail to treat Covid-19 in high-risk patients with mild to moderate disease https://t.co/h0JbQVNX0t
— CNN Breaking News (@cnnbrk) November 22, 2020
The FDA has issued an emergency use authorization for Regeneron's antibody cocktail to treat Covid-19 in high-risk patients with mild to moderate disease https://t.co/h0JbQVNX0t
— CNN Breaking News (@cnnbrk) November 22, 2020